[Bacteriological aspects of current antibacterial chemotherapy].
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002509:Cephaloridine / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004338:Drug Combinations; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004338:Drug Combinations; D005839:Gentamicins; D010406:Penicillins; D009268:Nalidixic Acid; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D014295:Trimethoprim; D008034:Lincomycin; D013752:Tetracycline; D013420:Sulfamethoxazole; D002509:Cephaloridine; D002512:Cephalothin; D010068:Oxacillin
Bakteriologische Gesichtspunkte zur heutigen antibakteriellen Chemotherapie.